Advances and perspective of the immunotherapy for relapsed/refractory multiple myeloma (interview)
.
Saved in:
| Main Author: | S. V. Semochkin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-01-01
|
| Series: | Онкогематология |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/518 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term continuous treatment as a new strategy for relapsed or refractory multiple myeloma
by: S. V. Semochkin
Published: (2020-07-01) -
Pomalidomide for the management of relapsed and refractory multiple myeloma: a case report and review of literature
by: S. V. Semochkin
Published: (2015-10-01) -
Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01) -
Lenalidomide for relapsed or refractory multiple myeloma
by: S. S. Bessmeltsev1, et al.
Published: (2014-07-01) -
The role of pomalidomide in treatment of relapse and refractory multiple myeloma
by: S. V. Voloshin, et al.
Published: (2022-01-01)